Literature DB >> 10615734

The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome.

M Smolka1, L G Schmidt.   

Abstract

AIMS: To determine the relationship between severity of opiate withdrawal and prior heroin dose and route of administration (smoking versus intravenous injection).
DESIGN: Retrospective analysis of withdrawal data and assessment of associations with baseline variables including heroin dose, route of administration, duration of use, concomitant use of cocaine, severity of opiate dependence, previous treatment, sex or age.
SETTING: Psychiatric inpatient unit specialized in withdrawal treatments. PARTICIPANTS: Twenty-two opiate addicts injecting or smoking heroin who were abruptly withdrawn after admission. MEASUREMENTS: Daily assessment of withdrawal severity with the Opiate Withdrawal Scale (OWS) during the first week after drug cessation.
FINDINGS: Severity and duration of withdrawal symptoms were greater in injectors compared to smokers (with comparable doses) and also in patients with higher heroin dose. Heroin dose and route of administration were related significantly to total and maximum withdrawal scores and together accounted for about 50% of variance. Similar levels of total withdrawal distress were associated with approximately five times higher heroin consumption in chasers than in injectors.
CONCLUSIONS: The impact of heroin dose and route of administration on withdrawal severity is marked. The influence of the route of administration on withdrawal severity might be due to differences in bioavailability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10615734     DOI: 10.1046/j.1360-0443.1999.94811919.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  11 in total

1.  Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.

Authors:  Karen L Skjei; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-24       Impact factor: 4.530

2.  Chasing the bean: prescription drug smoking among socially active youth.

Authors:  Brian C Kelly; Mike Vuolo; Mark Pawson; Brooke E Wells; Jeffrey T Parsons
Journal:  J Adolesc Health       Date:  2015-06       Impact factor: 5.012

3.  Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users.

Authors:  Jianrong Li; Jing Wang; Kunlun Tian; Yixin Wang; Lei Zhang; Hanju Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Medications for opioid use disorder during pregnancy: Access and continuity in a state women's prison facility, 2016-2019.

Authors:  Andrea K Knittel; Rita A Swartzwelder; Samantha Zarnick; Tamy Harumy Moraes Tsujimoto; Timelie Horne; Feng-Chang Lin; James Edwards; Elton Amos; James Alexander; John Thorp; Hendree E Jones
Journal:  Drug Alcohol Depend       Date:  2022-01-15       Impact factor: 4.492

5.  Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study.

Authors:  Eric A Woodcock; Leslie H Lundahl; Margit Burmeister; Mark K Greenwald
Journal:  Am J Addict       Date:  2015-04-24

6.  Strategies to avoid opiate withdrawal: implications for HCV and HIV risks.

Authors:  Pedro Mateu-Gelabert; Milagros Sandoval; Peter Meylakhs; Travis Wendel; Samuel R Friedman
Journal:  Int J Drug Policy       Date:  2009-09-27

7.  Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties.

Authors:  Marianne Seleman; Hélène Chapy; Salvatore Cisternino; Cindie Courtin; Maria Smirnova; Joël Schlatter; Fouad Chiadmi; Jean-Michel Scherrmann; Florence Noble; Cynthia Marie-Claire
Journal:  Psychopharmacology (Berl)       Date:  2014-04-05       Impact factor: 4.530

8.  Smoking heroin with cannabis versus injecting heroin: unexpected impact on treatment outcomes.

Authors:  Nirvana Morgan; William Daniels; Ugasvaree Subramaney
Journal:  Harm Reduct J       Date:  2019-12-05

9.  Increased Expression of Plasma miRNA-320a and let-7b-5p in Heroin-Dependent Patients and Its Clinical Significance.

Authors:  Haixiong Liu; Wenjin Xu; Jiying Feng; Hong Ma; Jianbin Zhang; Xiaohu Xie; Dingding Zhuang; Wenwen Shen; Huifen Liu; Wenhua Zhou
Journal:  Front Psychiatry       Date:  2021-06-29       Impact factor: 4.157

10.  Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa.

Authors:  Andrew Scheibe; Shaun Shelly; Tara Gerardy; Zara von Homeyer; Andrea Schneider; Kalvanya Padayachee; Shalon Balaguru Naidoo; Klaas Mtshweni; Ayanda Matau; Harry Hausler; Monique Marks
Journal:  Addict Sci Clin Pract       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.